相似文献
1
Genetic predisposition to lung cancer.
Br J Cancer. 1990 Feb;61(2):195-206. doi: 10.1038/bjc.1990.37.
2
Carcinogen metabolism and individual susceptibility.
Scand J Work Environ Health. 1992;18 Suppl 1:17-21.
3
Antipyrine metabolism in lung cancer patients and their relatives.
Rocz Akad Med Bialymst. 1997;42 Suppl 1:297-308.
4
Debrisoquine metabolism and genetic predisposition to lung cancer.
Br J Cancer. 1989 May;59(5):686-7. doi: 10.1038/bjc.1989.142.
5
Chromosomal analysis of a human lung adenocarcinoma cell line, AGZY83-A.
Chin Med J (Engl). 1987 Mar;100(3):198-203.
6
Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
Drug Metab Dispos. 1980 Jul-Aug;8(4):218-22.
7
The influence of changes in dietary fat on the clearance of antipyrine and 4-hydroxylation of debrisoquine.
Br J Clin Pharmacol. 1980 Mar;9(3):283P. doi: 10.1111/j.1365-2125.1980.tb04843.x.
8
Absence of seasonal variation in antipyrine metabolism.
Clin Pharmacol Ther. 1982 Feb;31(2):144-50. doi: 10.1038/clpt.1982.23.
9
Aryl hydrocarbon hydroxylase in man and lung cancer.
Hum Genet Suppl. 1978(1):161-8. doi: 10.1007/978-3-642-67179-1_21.
10
Strain differences of antipyrine, trimethadione, and debrisoquine metabolism in female rats.
Res Commun Chem Pathol Pharmacol. 1990 Aug;69(2):233-6.
引用本文的文献
1
Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women.
Breast Cancer Res. 2004;6(4):R460-73. doi: 10.1186/bcr814. Epub 2004 Jun 15.
2
Metabolic activation of toxins: tissue-specific expression and metabolism in target organs.
Environ Health Perspect. 1997 Jun;105 Suppl 4(Suppl 4):767-74. doi: 10.1289/ehp.97105s4767.
3
Cytogenetic findings on shoe workers exposed long-term to benzene.
Environ Health Perspect. 1996 Dec;104 Suppl 6(Suppl 6):1313-7. doi: 10.1289/ehp.961041313.
4
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
Br J Clin Pharmacol. 1990 Oct;30(4):653-6. doi: 10.1111/j.1365-2125.1990.tb03832.x.
5
The second Bagshawe lecture. Matching basic research to the management of cancer: the view from the other side of the fence.
Br J Cancer. 1990 Sep;62(3):341-7. doi: 10.1038/bjc.1990.294.
6
Oxidative polymorphism of debrisoquine is not related to human colo-rectal cancer.
Eur J Clin Pharmacol. 1991;40(5):525-7. doi: 10.1007/BF00315234.
7
Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients.
Clin Investig. 1992 Mar-Apr;70(3-4):307-19. doi: 10.1007/BF00184667.
本文引用的文献
1
Familial aggregation of lung cancer among hospital patients.
Public Health Rep (1896). 1963 Apr;78(4):277-83.
2
Familial aggregation of lung cancer in humans.
J Natl Cancer Inst. 1963 Feb;30:289-312.
3
Blood groups and carcinoma of the lung.
Med J Aust. 1961 Jul 8;48(2):61-2. doi: 10.5694/j.1326-5377.1961.tb82571.x.
4
Blood groups and disease: carcinoma of various organs.
Med J Aust. 1958 Dec 20;45(25):835-7.
5
The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast, and bronchus; an association between the ABO groups and peptic ulceration.
Br Med J. 1954 Aug 7;2(4883):315-21. doi: 10.1136/bmj.2.4883.315.
6
Monooxygenase, epoxide hydrolase, and glutathione-S-transferase activities in human lung. Variation between groups of bronchogenic carcinoma and non-cancer patients and interindividual differences.
Carcinogenesis. 1980;1(10):827-35. doi: 10.1093/carcin/1.10.827.
7
Enhanced benzo(a)pyrene metabolism and formation of DNA adducts in monocytes of patients with lung cancer.
J Cancer Res Clin Oncol. 1980;96(3):295-302. doi: 10.1007/BF00408102.
8
Correlation of inducibility of aryl hydrocarbon hydroxylase with susceptibility to 3-methylcholanthrene-induced lung cancers.
Cancer Lett. 1980 Jun;9(4):277-84. doi: 10.1016/0304-3835(80)90018-x.
9
A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.
J Med Genet. 1980 Apr;17(2):102-5. doi: 10.1136/jmg.17.2.102.
10
Variation of microsomal mixed function oxidase(s) and human lung cancer.
Cancer. 1980 Mar 15;45(6):1438-42. doi: 10.1002/1097-0142(19800315)45:6<1438::aid-cncr2820450623>3.0.co;2-e.
Zotero 插件